CN1415323A - Patent Chinese medicine for treating diabetes - Google Patents
Patent Chinese medicine for treating diabetes Download PDFInfo
- Publication number
- CN1415323A CN1415323A CN 02127906 CN02127906A CN1415323A CN 1415323 A CN1415323 A CN 1415323A CN 02127906 CN02127906 CN 02127906 CN 02127906 A CN02127906 A CN 02127906A CN 1415323 A CN1415323 A CN 1415323A
- Authority
- CN
- China
- Prior art keywords
- grams
- folium mori
- chinese patent
- patent medicine
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese patent medicine for treating insulin-independent diabetes and its complications is prepared from 7 Chinese-medicinal materials including scutellaria root, mulberry lefa, arctium fruit, barbat skullcap, etc. Its advantages are high curative effect and low cost.
Description
Technical field: the present invention is a kind of Chinese patent medicine for the treatment of diabetes, particularly the Chinese patent medicine of making of pure Chinese herbal medicine.
Technical background: diabetes are frequently-occurring diseases of serious harm human health, and at present there is the patient in China near 20,000,000, and have and increase trend year by year, and case fatality rate is only second to malignant tumor and cardiovascular disease, is to jeopardize the third-largest disease of human life; Diabetes do not heal all the life, complication extensively and seriously, because insulin lacks relatively or definitely in the blood flow, cause sugar, fat, protein metabolism disorder, cause the rising of hypertension, hyperlipidemia and blood viscosity, extensively microangiopathies of the whole body appears in middle and advanced stage, and wherein the patient of 70-80% dies from the cardiovascular diseases, and renal failure and cerebrovascular accident are the common causes of death of middle and elderly diabetic patient; To what this sick Drug therapy adopted be both at home and abroad at present: 1, biguanides medicine treatment, its curative effect is low, side effect is big, for a long time with producing hyperlactacidemia; 2, iodine ureas medicine is treated it for a long time with infringement liver, kidney and hemocyte, and with the sulphonamides cross allergy, the later stage produces secondary failure; 3, insulinize, the easily generation antibody of using of a specified duration, biological activity reduces, and dosage increase, generation hyperinsulinemia promote the microangiopathies generation and develop.Though China recent years has some to treat this sick Chinese patent medicine, because DeGrain, the patient still has to rely on some Western medicine, so still has the problems referred to above.
Summary of the invention: the objective of the invention is to: a kind of Chinese patent medicine for the treatment of diabetes is provided, this medicine is to develop on the proved recipe basis that the compatriot of China Miao ethnic group uses for a long time, have YIN nourishing and the production of body fluid promoting, grow the function of spleen the kidney invigorating, QI invigorating blood sugar lowering, be used for diabetes, cure mainly non-insulin-dependent diabetes mellitus and retina, kidney, blood vessel, neurological complication; The present invention constitutes like this: it is made of Radix Scutellariae 580-650, Folium Mori 250-230, Fructus Arctii 230-300, Radix Wahlenbergiae Marginatae 150-220, Herba Scutellariae Barbatae 140-200, Rhizoma Polygonati Odorati 100-140, Semen Celosiae 80-110; Specifically: form by Radix Scutellariae 620 grams, Folium Mori 285 grams, Fructus Arctii 260 grams, Radix Wahlenbergiae Marginatae 180 grams, Herba Scutellariae Barbatae 170 grams, Rhizoma Polygonati Odorati 120 grams, Semen Celosiae 93 grams.More specific method is: get the part powder of Folium Mori and be broken into fine powder, all the other Folium Mori and other medical material water decoct, extracting solution concentrates, and add Folium Mori fine powder, drying, pulverizing then,
To medicine, can be made into the dosage form of needs according to prior art; The extraction of the active ingredient of medical material can be adopted solvent, comprises method and supercritical carbon dioxide extraction that water, alcohol decoct, soak.Compared with prior art: the present invention constitute fairly simple, manufacture method is easy, cost of drugs is cheap, the patient is acceptant, medicine really has YIN nourishing and the production of body fluid promoting, grows the function of spleen the kidney invigorating, QI invigorating blood sugar lowering, is used for diabetes, cures mainly non-insulin-dependent diabetes mellitus and retina, kidney, blood vessel, neurological complication; Effect is apparent in view, and product has obtained the approval of national drug authorities, and its trade name is " a YULAN Jiangtang capsule ", and instructions of taking is: oral, every day 2-3 time, each 3.
Embodiments of the invention 1: form by Radix Scutellariae 620 grams, Folium Mori 285 grams, Fructus Arctii 260 grams, Radix Wahlenbergiae Marginatae 180 grams, Herba Scutellariae Barbatae 170 grams, Rhizoma Polygonati Odorati 120 grams, Semen Celosiae 93 grams, more specific method is: get 100 gram powder of Folium Mori and be broken into fine powder, all the other Folium Mori and other medical material water decoct, extracting solution concentrates, add Folium Mori fine powder, drying, pulverizing then, obtain the extract fine powder, in incapsulating.
Embodiments of the invention 2: it is made up of Radix Scutellariae 580 grams, Folium Mori 250 grams, Fructus Arctii 230 grams, Radix Wahlenbergiae Marginatae 150 grams, Herba Scutellariae Barbatae 140 grams, Rhizoma Polygonati Odorati 100, Semen Celosiae 80 grams; Specifically: get 80 gram powder of Folium Mori and be broken into fine powder, all the other Folium Mori and other medical material extract active ingredient with the way that ethanol carries out alcohol extraction, then extracting solution are concentrated, and add Folium Mori fine powder, drying, pulverizing again, obtain medicine, can be made into granule according to prior art.
Embodiments of the invention 3: it is made of Radix Scutellariae 650 grams, Folium Mori 230 grams, Fructus Arctii 300 grams, Radix Wahlenbergiae Marginatae 220 grams, Herba Scutellariae Barbatae 200 grams, Rhizoma Polygonati Odorati 140 grams, Semen Celosiae 110 grams, the active ingredient that can adopt super critical CO 2 technology to extract Chinese herbal medicine, the extraction of substance that obtains are made into the dosage form that needs according to prior art.
Claims (4)
1, a kind of Chinese patent medicine for the treatment of diabetes is characterized in that: according to weight proportion: be made of Radix Scutellariae 580-650, Folium Mori 250-230, Fructus Arctii 230-300, Radix Wahlenbergiae Marginatae 150-220, Herba Scutellariae Barbatae 140-200, Rhizoma Polygonati Odorati 100-140, Semen Celosiae 80-110.
2, according to the Chinese patent medicine of the described this treatment diabetes of claim 1, it is characterized in that: constitute by Radix Scutellariae 620 grams, Folium Mori 285 grams, Fructus Arctii 260 grams, Radix Wahlenbergiae Marginatae 180 grams, Herba Scutellariae Barbatae 170 grams, Rhizoma Polygonati Odorati 120 grams, Semen Celosiae 93 grams.
3, according to the Chinese patent medicine of claim 1,2 described this treatment diabetes, it is characterized in that: get the part powder of Folium Mori and be broken into fine powder, all the other Folium Mori and other medical material water decoct, extracting solution concentrates, add Folium Mori fine powder, drying, pulverizing then, obtain medicine, can be made into the dosage form of needs according to prior art.
4, according to the Chinese patent medicine of claim 1,2 or 3 described this treatment diabetes, it is characterized in that: the extraction of the active ingredient of medical material can be adopted solvent, comprises method and supercritical carbon dioxide extraction that water, alcohol decoct, soak.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021279063A CN1172705C (en) | 2002-11-29 | 2002-11-29 | Patent Chinese medicine for treating diabetes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021279063A CN1172705C (en) | 2002-11-29 | 2002-11-29 | Patent Chinese medicine for treating diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1415323A true CN1415323A (en) | 2003-05-07 |
CN1172705C CN1172705C (en) | 2004-10-27 |
Family
ID=4745832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021279063A Expired - Lifetime CN1172705C (en) | 2002-11-29 | 2002-11-29 | Patent Chinese medicine for treating diabetes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1172705C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101518622B (en) * | 2008-02-27 | 2011-01-12 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetes complicated with urinary infection |
CN103432202A (en) * | 2013-09-16 | 2013-12-11 | 河南中医学院 | Method for extracting hypoglycemic substance from sculellaria barbata and application thereof |
CN104940663A (en) * | 2014-03-27 | 2015-09-30 | 潘祖贤 | Medicine for treating diabetes |
CN107467305A (en) * | 2017-09-19 | 2017-12-15 | 常州瑞坦商贸有限公司 | A kind of preparation method of blood-sugar reducing tea |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1318042C (en) * | 2004-12-28 | 2007-05-30 | 崔开德 | Application of barbat skullcap in preparing medication for treating diabetes |
-
2002
- 2002-11-29 CN CNB021279063A patent/CN1172705C/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101518622B (en) * | 2008-02-27 | 2011-01-12 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetes complicated with urinary infection |
CN103432202A (en) * | 2013-09-16 | 2013-12-11 | 河南中医学院 | Method for extracting hypoglycemic substance from sculellaria barbata and application thereof |
CN103432202B (en) * | 2013-09-16 | 2015-05-20 | 河南中医学院 | Method for extracting hypoglycemic substance from sculellaria barbata and application thereof |
CN104940663A (en) * | 2014-03-27 | 2015-09-30 | 潘祖贤 | Medicine for treating diabetes |
CN107467305A (en) * | 2017-09-19 | 2017-12-15 | 常州瑞坦商贸有限公司 | A kind of preparation method of blood-sugar reducing tea |
Also Published As
Publication number | Publication date |
---|---|
CN1172705C (en) | 2004-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1723926A (en) | Traditional Chinese medicine liquor and preparation method thereof | |
CN101485825A (en) | Chinese medicine capsule for treating diabetes | |
CN102284022A (en) | Cough medicament and preparation method thereof | |
CN101926942A (en) | Glucose-lowering health care medicinal tea and preparation method thereof | |
CN101856405A (en) | Medicinal composition for treating type II diabetes mellitus and preparation method thereof | |
CN1172705C (en) | Patent Chinese medicine for treating diabetes | |
CN102091225A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
CN104666849A (en) | Hypoglycemic health product and preparation method thereof | |
CN101279034B (en) | Combined Chinese medicament for curing diabetic with combined internal and external therapies and preparation thereof | |
CN105994867A (en) | Chocolate with effect of improving immunity and preparation method thereof | |
CN1336212A (en) | Diabetes treating medicine | |
CN1253190C (en) | Medicine for treating diabetes | |
CN1792372A (en) | Traditional Chinese medicine prepn. for treating diabetes | |
CN101953959A (en) | Chinese medicament for treating diabetic gastroparalysis | |
CN101843740B (en) | Chinese medicament for treating climacteric syndromes | |
CN111888431A (en) | Composition for treating diabetes and preparation method thereof | |
CN101850071A (en) | Chinese medicament for treating chronic nephritis | |
CN1151813C (en) | Traditional Chinese medicine composition for curing insomnia | |
CN1418667A (en) | Chinese patent drug for treating diabets mellitus | |
CN101396454B (en) | Traditional Chinese medicine for treating diabetic skin pruritus | |
CN101912584A (en) | Medicine for treating melancholia and preparation method thereof | |
CN101637573B (en) | Medicinal composition for treating diabetes and preparation method thereof | |
CN101081264A (en) | Chinese medicine for treating hypertension and method for making same | |
CN104940490A (en) | Hypoglycemic drug with traditional Chinese herbal medicine and active catalytic elements and preparation method of hypoglycemic drug | |
CN1306830A (en) | Medicine for treating type II diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 550018 Guizhou city of Guiyang province high tech Industrial Development Zone of High Road No. 228 Patentee after: Guizhou Jianxing Pharmaceutical Co.,Ltd. Address before: 550004 Xinhua Road, Guiyang, China, No. 80 Fu Zhong commercial building, 14F, Patentee before: Guizhou Jianxing Pharmaceutical Co.,Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20041027 |